Dyne Therapeutics

About:

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Website: https://www.dyne-tx.com/

Twitter/X: dyne_tx

Top Investors: RA Capital Management, Wellington Management, Franklin Templeton, Atlas Venture, Surveyor Capital

Description:

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, cardiac and smooth muscle with unprecedented precision, enabling patients to restore muscle strength and transform their lives.

Total Funding Amount:

$940M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2018-01-01

Founders:

Phillip Samayoa, Romesh Subramanian

Number of Employees:

101-250

Last Funding Date:

2024-05-21

IPO Status:

Public

© 2025 bioDAO.ai